Lennox–Gastaut syndrome (LGS) is a severe developmental epileptic encephalopathy. Adjunctive cannabidiol resulted in a greater reduction in seizure frequency and a higher rate of AEs than placebo in 2 RCTs https://t.co/gILMWU3SQq
RT @drpaolandmd: In this systematic review adjunctive #CBD resulted in a greater reduction in #seizures frequency and a higher rate of adve…
RT @drpaolandmd: In this systematic review adjunctive #CBD resulted in a greater reduction in #seizures frequency and a higher rate of adve…
RT @drpaolandmd: In this systematic review adjunctive #CBD resulted in a greater reduction in #seizures frequency and a higher rate of adve…
For the benefit of friends at @CMA_Docs
In this systematic review adjunctive #CBD resulted in a greater reduction in #seizures frequency and a higher rate of adverse events than placebo in patients with LGS presenting seizures uncontrolled by concomitant AEs #epilepsy #MedicalCannabis https://t